Contact us here!
Contact us for questions, general inquiries, or to request a quote.
By submitting this form, I consent to the processing of my personal data as explained in Ossiform's Privacy Policy.
Ossiform welcomes Gijs Klarenbeek as Clinical- / Medical Affairs Advisor
Ossiform welcomes Gijs Klarenbeek as Clinical- / Medical Affairs Advisor
(April 24, 2026) Ossiform is pleased to announce that Gijs Klarenbeek, MD, has joined the company as Clinical- / Medical Affairs Advisor.
In this role, Gijs will support the continued strengthening of Ossiform’s clinical and medical affairs activities as the company prepares for launch and clinical adoption in the United States and initiates the studies to obtain the CE mark.
Gijs will contribute to the successful clinical implementation of Ossiform’s bio-integrative, 3D printed bone substitutes and surgical instrumentation across the U.S. and Europe. His work will focus on ensuring robust evidence generation and dissemination, supporting surgeon training and medical education, collaborating closely with key opinion leaders, CROs, and contributing to post-market regulatory and adoption activities.
Gijs is a trained medical doctor with surgical residency in Orthopedics, giving him a strong clinical foundation and firsthand understanding of surgical practice. He brings extensive experience from clinical development and medical affairs roles within leading medical device companies, including Johnson & Johnson, Boston Scientific, Medtronic, and Sequana Medical. Across these roles, he has worked at the interface between clinical research, medical strategy, physician engagement, and the introduction of innovative medical technologies into daily clinical practice.
In addition, Gijs serves as an Advisory Board member at the clinical research organizations XPER Research and QbD, further strengthening his expertise in clinical research strategy and execution.
The engagement of Gijs reflects Ossiform’s ambition to build a robust and scalable clinical and medical affairs function that combines strong clinical operations with strategic alignment across medical, regulatory, and commercial activities.
“We are very pleased to welcome Gijs to Ossiform,” said CEO, Thea Wulff Olesen. “His clinical background and broad MedTech experience will be valuable as we continue to strengthen our clinical foundation and support the adoption of Ossiform’s solutions.”
About Ossiform®
Ossiform® is a UK and Denmark based MedTech company that is forming a new generation of structural bioactive bone substitutes to reduce complications, improve functional outcomes, and accelerate recovery. We are continuously working to redefine bone replacements through progressive research and close collaboration with physicians and industry partners. Our patient-centric approach and commitment to innovation, quality, and progress steer our efforts to provide best-in-class implant solutions that facilitate the natural forming of new bone.
Website: www.ossiform.com
LinkedIn: Ossiform